)
Sonia Feau
Director of Biology,
Onchilles Pharma
Sonia Feau is Director of Biology at Onchilles Pharma and is responsible for managing activities related to the overall execution of R&D initiatives to move innovative therapeutic drug candidates into the clinic and advance Onchilles’ platform and future product portfolios. Sonia has 20 years of immuno-oncology experience. Prior to Onchilles Pharma, Sonia worked at Oncorus where she led the Immunology group responsible for designing, optimizing and evaluating new immune enhancer payloads to be expressed by oncolytic viruses, at Merck & Co. and Merrimack Pharmaceuticals, she proposed and evaluated several new immuno-oncology targets. Sonia’s experience in Immunology spans both innate and adaptive immune responses. She received her post-doctoral training at the La Jolla Institute for Immunology in San Diego, where she studied CD8 memory T cells. Sonia received her Ph.D. in Immunology and Biotechnology from the University of Milano-Bicocca, Italy and University Toulouse III, France studying dendritic cells biology.